Religare Enterprises valuation

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Price multiples — at each FY-end close
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
144.76×————
2.47×————
0.80×————
3.97×————
Enterprise multiples
0.89×————
133.54×————
1,081.68×————
Yield
0.7%————
25.2%————
Reference — adjusted share basis
₹216.14————
₹1.49₹2.59₹3.77₹7.02₹92.85
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

RELIGARE₹216.14

Religare Enterprises Ltd.

· Banking & Finance
₹ CrorePeersSTARHEALTHPSBPRUDENTSHAREINDIASOUTHBANKSTYLMAHSCOOTERTMBMcap ₹7,173 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Price Multiples — at each FY-end close
P/E————144.76
P/B————2.47
P/Sales————0.80
Price to Free Cash Flow————3.97
Enterprise Multiples
EV/Sales————0.89
EV/EBITDA————133.54
EV/EBIT————1,081.68
Yield
Earnings Yield %————0.69
FCF Yield %————25.20
Reference — adjusted share basis
Price (FY-end close, adj.)————216.14
EPS (adj.)92.857.023.772.591.49
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.